Table 2 Outcomes of the 14 including articles
Study (author/year) | BMD (mean ± SD) (g/cm2) | BAP (mean ± SD) (U/L) (BPs vs. control) | NTX-I (mean ± SD) (nmol/mmol Cr) (BPs vs. control) | ||
|---|---|---|---|---|---|
1 year (BPs vs. control) | 2–4 years (BPs vs. control) | ≥ 5 years (BPs vs. control) | |||
Tapaninen TS/2010 [18] | − 0.04 ± 0.09 vs. − 0.12 ± 0.10 | − 0.05 ± 0.12 vs. − 0.18 ± 0.21 | − 0.06 ± 0.12 vs. − 0.16 ± 0.24 | NA | NA |
Trevisan C/2010 [19] | − 0.04 ± 0.07 vs. − 0.07 ± 0.08 | NA | NA | NA | NA |
Arabmotlagh M/2009 [20] | − 0.02 ± 0.16 vs. − 0.04 ± 0.09 | NA | − 0.02 ± 0.17 vs. − 0.06 ± 0.20 | NA | NA |
Yamasaki S/2007 [21] | NA | NA | NA | 21.5 ± 7.7 vs. 31.2 ± 9.6 | 39.2 ± 15.9 vs.70.3 ± 27.7 |
Fokter SK/2006 [22] | − 0.06 ± 0.07 vs. − 0.06 ± 0.23 | NA | NA | NA | NA |
Arabmotlagh M/2006 [23] | 0 ± 0.16 vs. − 0.07 ± 0.22 | NA | NA | 17.9 ± 6 vs. 27.1 ± 8.9 | NA |
Yamaguchi K/2004 [24] | − 0.06 ± 0.12 vs. − 0.12 ± 0.14 | − 0.09 ± 0.13 vs. − 0.13 ± 0.13 | NA | 25.2 ± 6.6 vs. 29.6 ± 8.7 | 52.5 ± 29.2 vs. 71.3 ± 17.8 |
Iwamoto N/2011 [25] | 0 ± 0.12 vs. − 0.08 ± 0.14 | NA | NA | NA | NA |
Kinov P/2006 [26] | NA | NA | NA | 19.93 ± 6.6 vs. 26.9 ± 5.9 | NA |
Shetty N/2006 [27] | − 0.01 ± 0.07 vs. − 0.02 ± 0.14 | − 0.02 ± 0.05 vs. − 0.01 ± 0.16 | − 0.02 ± 0.01 vs. − 0.03 ± 0.2 | NA | NA |
Scott DF/2013 [28] | 0.80 ± 10.4 vs. − 6.03 ± 13.2 | − 0.16 ± 14.0 vs. − 7.13 ± 12.7 | NA | NA | NA |
Yukizawa Y/2017 [29] | − 0.04 ± 0.02 vs. − 0.13 ± 0.02 | NA | − 0.12 ± 0.03 vs. − 0.21 ± 0.02 | NA | NA |
Muren O/2015 [30] | NA | − 0.19 ± 0.02 vs. − 0.22 ± 0.03 | NA | NA | NA |
Nehme A/2003 [31] | − 0.24 ± 0.07 vs. − 0.32 ± 0.07 | − 0.09 ± 0.06 vs. − 0.16 ± 0.06 | NA | NA | NA |